Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • GillermoPonz
    Junior Member
    • Oct 2014
    • 6

    #1

    How would sequence overrepresentation affect the quality of a De Novo assembly?

    Hello everyone,

    I am trying to prepare two files containing several millions of illumina RNA pair-end reads for a De Novo assembly using Trinity, and, as I posted the other day I have some doubts about how to prepare the datasets in order to obtain the best transcriptome assembly.

    In this case my doubt is about haw would affect the assembly the overrepresentation of some sequences. My datasets have a deep coverage and, as a result, I have a great overrepresentation of some (non-artifact) sequences (some of them representing up to the 0.2% of the total number of sequences) and a huge level of sequence duplication (73% aprox.). Are this parameters important for the quality of the assembly? How can I solve this if it is important? Should I normalized the datasets before performing the assembly?

    I would be very grateful if someone can help me with this (at least for me) puzzling issue.
    Last edited by GillermoPonz; 04-15-2015, 01:51 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...